Literature DB >> 12794633

Is a revision of the "nuclear cardiology warranty" in order?

Gregory S Thomas, Michael I Miyamoto.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12794633     DOI: 10.1016/s1071-3581(03)00439-2

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  24 in total

1.  Updated imaging guidelines for nuclear cardiology procedures, part 1.

Authors: 
Journal:  J Nucl Cardiol       Date:  2001 Jan-Feb       Impact factor: 5.952

Review 2.  Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age.

Authors:  K A Brown
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

3.  Clinical relevance of a normal myocardial perfusion scintigraphic study. American Society of Nuclear Cardiology.

Authors:  T M Bateman
Journal:  J Nucl Cardiol       Date:  1997 Mar-Apr       Impact factor: 5.952

4.  Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction.

Authors:  T Sharir; G Germano; X Kang; H C Lewin; R Miranda; I Cohen; R D Agafitei; J D Friedman; D S Berman
Journal:  J Nucl Med       Date:  2001-06       Impact factor: 10.057

5.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction.

Authors:  R Hachamovitch; D S Berman; L J Shaw; H Kiat; I Cohen; J A Cabico; J Friedman; G A Diamond
Journal:  Circulation       Date:  1998-02-17       Impact factor: 29.690

6.  Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness.

Authors:  Rory Hachamovitch; Daniel S Berman; Hosen Kiat; Ishac Cohen; John D Friedman; Leslee J Shaw
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

7.  Prognostic value of myocardial perfusion imaging in patients with high exercise tolerance.

Authors:  S N Chatziioannou; W H Moore; P V Ford; R E Fisher; V V Lee; C Alfaro-Franco; R D Dhekne
Journal:  Circulation       Date:  1999-02-23       Impact factor: 29.690

8.  Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography.

Authors:  D S Berman; R Hachamovitch; H Kiat; I Cohen; J A Cabico; F P Wang; J D Friedman; G Germano; K Van Train; G A Diamond
Journal:  J Am Coll Cardiol       Date:  1995-09       Impact factor: 24.094

9.  Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions.

Authors:  G V Heller; S D Herman; M I Travin; J I Baron; C Santos-Ocampo; J R McClellan
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

10.  Exercise thallium-201 scintigraphy and prognosis in typical angina pectoris and negative exercise electrocardiography.

Authors:  C N Bairey; A Rozanski; J Maddahi; K J Resser; D S Berman
Journal:  Am J Cardiol       Date:  1989-08-01       Impact factor: 2.778

View more
  2 in total

Review 1.  Role of computed tomography and perfusion imaging in patients with known or suspected coronary artery disease.

Authors:  Paolo Raggi; Gregory S Thomas
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

2.  Prognostic value of myocardial perfusion scintigraphy in elderly patients with hypertension: a 10-year follow-up analysis.

Authors:  Luca Nai Fovino; Giorgio Saladini; Anna Rita Cervino; Francesca Saladini; Michele Gregianin; Renato Razzolini; Laura Evangelista
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-15       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.